Tag: Phase-2
Eyestem raises funds to advance Eyecyte-RPE™ through phase 2 clinical trial...
The capital will enable completion of the ongoing Phase 2 clinical trial in India and support preparations for filing an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA)
SunAct Cancer Institute ties up with Singapore’s CytoMed for phase 2...
This is a cutting-edge cancer treatment that uses special immune cells called Gamma Delta T-Cells
United States opens clinical trial enrollment for treatment of progressive Parkinsonian...
Alterity Therapeutics launches ATH434 Phase 2 Clinical Trial in the United States for the treatment of individuals with Multiple System Atrophy
DCGI green signal to COVAXIN’s Phase II/III clinical trial in 2-18...
Hyderabad based Bharat Biotech to conduct clinical trials in 525 healthy volunteers........................
Sun Pharma initiates Phase 2 clinical trial of Psoriasis drug
SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis, are also expected to be initiated soon......................
Sun Pharma seals US$ 145 million deal with SPARC over potential...
The two companies have announced a worldwide licensing agreement on the development and commercialization of SCD-044 which is being evaluated as a potential oral treatment for atopic dermatitis, psoriasis and other auto-immune disorders.............
Vyome Therapeutics begins phase 2 trial of its drug for acne...
The company has dosed the first patient in its Phase 2 trial of the Company’s lead clinical candidate, VB-1953, for the treatment of moderate to severe inflammatory acne vulgaris......................
Zydus Cadila begins phase-2 trial of drug to cure anaemia in...
Zyani1, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), is being tested as a viable treatment for anaemia associated with chronic kidney disease (CKD)...........
India to soon launch its indigenously developed vaccine against Leprosy
Developed by Dr G P Talwar, Founding Director of National Institute of Immunology, this exclusive vaccine for leprosy will be piloted in five districts....